Filippo Andrea Giovanni Perozzo

Dr. Filippo Andrea Giovanni Perozzo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ACAnna Carolo
Anna Carolo
LMLuca Melotti
Luca Melotti
GZGiulia Zivelonghi
Giulia Zivelonghi
RSRoberta Sacchetto
Roberta Sacchetto
EAEylem Emek AKYÜREK
Eylem Emek AKYÜREK
MPMarco Patruno
Marco Patruno
The mutable collagenous tissue (MCT) of echinoderms possesses biological peculiarities that facilitate native collagen extraction and employment for biomedical applications such as regenerative purposes for the treatment of skin wounds. Strategies for skin regeneration have been developed and dermal substitutes have been used to cover the lesion to facilitate cell proliferation, although very little is known about the application of novel matrix obtained from marine collagen. From food waste we isolated eco-friendly collagen, naturally enriched with glycosaminoglycans, to produce an innovative marine-derived biomaterial assembled as a novel bi-layered skin substitute (Marine Collagen Dermal Template or MCDT). The present work carried out a preliminary experimental in vivo comparative analysis between the MCDT and Integra, one of the most widely used dermal templates for wound management, in a rat model of full-thickness skin wounds. Clinical, histological, and molecular evaluations showed that the MCDT might be a valuable tool in promoting and supporting skin wound healing: it is biocompatible, as no adverse reactions were observed, along with stimulating angiogenesis and the deposition of mature collagen. Therefore, the two dermal templates used in this study displayed similar biocompatibility and outcome with focus on full-thickness skin wounds, although a peculiar cellular behavior involving the angiogenesis process was observed for the MCDT.

16 September 2024 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
SKSamuel Alfons Christoph Knoedler
Samuel Alfons Christoph Knoedler
FPFilippo Andrea Giovanni Perozzo
Filippo Andrea Giovanni Perozzo
JJJun Jiang
Jun Jiang
MKMychajlo Kosyk
Mychajlo Kosyk
MAMichael Alfertshofer
Michael Alfertshofer
BKBong-Sung Kim
Bong-Sung Kim

1 February 2021 in Burns
Verified
Journal Article
Closed access
BABruno Azzena
Bruno Azzena
FPFilippo Andrea Giovanni Perozzo
Filippo Andrea Giovanni Perozzo
ALAlberto De Lazzari
Alberto De Lazzari
GVGiovanni Valotto
Giovanni Valotto
APAlex Pontini
Alex Pontini

10 February 2022 in American Journal of Case Reports
Verified
Journal Article
Open access
FPFilippo Andrea Giovanni Perozzo
Filippo Andrea Giovanni Perozzo
LPLeonardo Punzi
Leonardo Punzi
ACAlfio Luca Costa
Alfio Luca Costa
FBFranco Bassetto
Franco Bassetto
Unusual clinical course Calcium pyrophosphate dihydrate deposition disease includes a variety of clinical syndromes, including acute calcium pyrophosphate (CPP) crystal arthritis. Most patients with CPP crystal arthritis have a primary/idiopathic form presenting with severe pain, swelling, and stiffness. COVID-19 infection, which originated in China in December 2019, required extraordinary efforts to develop and test new vaccines to halt the pandemic. The Vaxzervria vaccine has shown excellent safety and efficacy in phase 3 trials with a mechanism based on the expression of the SARS-CoV-2 spike protein gene coding for the S-antigen, which stimulates the immune response. We describe an acute event of crystal arthritis after a carpal tunnel syndrome release followed by administration of the second dose of anti-COVID-19 Vaccine Oxford-AstraZeneca (ChAdOx1 nCoV-19). Medical treatment resulted in full resolution of the symptoms in 2 weeks. Although most episodes of acute arthritis happen spontaneously, certain factors may trigger the acute CPP crystal arthritis such as intercurrent illnesses or surgeries. Although the association between carpal tunnel syndrome and CPP arthritis has been known for over 40 years, surgical release of the carpal ligament has always been associated with full resolution of symptoms. This is the first case report describing an exacerbation after carpal canal release, concomitant with the administration of the vaccine. According to our opinion, the vaccination associated with a prior surgery in the same anatomical site could have synergically triggered the arthritis flare-up, in a predisposed patient, with a mechanism still unknown.

21 September 2024 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
FAFuad Abbas
Fuad Abbas
RKRyan Khalaf
Ryan Khalaf
JRJose Reyes
Jose Reyes
RFR’aY Fodor
R’aY Fodor
FPFilippo Andrea Giovanni Perozzo
Filippo Andrea Giovanni Perozzo
BGBahar Bassiri Gharb
Bahar Bassiri Gharb

30 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AFAlberto Franchi
Alberto Franchi
FPFilippo Andrea Giovanni Perozzo
Filippo Andrea Giovanni Perozzo
CTCesare Tiengo
Cesare Tiengo
JWJonas Walber
Jonas Walber
APAlice Parisato
Alice Parisato
Florian Johannes JungFlorian Johannes Jung
Florian Johannes Jung
Background: In reconstructive microsurgery, the aesthetic outcome has gained increasing importance, and new applications of flaps have been explored, focusing on improved donor site concealment. This paper presents our experience with flaps gaining popularity in reconstructive microsurgery, specifically the SCIP/SIEA and PAP flaps. Methods: Since August 2022, SCIP/SIEA and PAP flaps have been offered for soft tissue reconstruction across all body regions. These flaps were added to the other traditionally offered free flaps, such as RFF, mSAP, ALT, DIEP, and LD. Where the defect could be equally reconstructed using flaps from various donor sites, the choice of donor site was left to the patient. In all other cases, the donor site was selected by the surgeon according to clinical needs. This retrospective study analyzes the first author’s experience with the SCIP/SIEA and PAP flaps, providing an overview of their applications, outcomes, advantages, and disadvantages. Results: A total of 79 patients were reconstructed with 86 free flaps during the study period. The SCIP/SIEA flap was used in 54 patients, and the PAP flap in 18 patients. Flaps other than SCIP/SIEA were used in the remaining seven. Among the 27 patients who were given the option to choose their donor site, 8 selected either the abdomen or inner thigh (5 and 3 cases, respectively). The remaining 19 patients expressed no preference and left the choice to the surgeon. Defects involved the head and neck in 30 patients (38.0%), extremities in 25 (31.7%), the breast in 23 (29.1%), and the trunk in 1 patient (1.3%). Major complications occurred in 12 patients (15.2%) while minor complications managed conservatively occurred in 18 patients (22.8%). Four flaps (4.7% of all flaps) were lost. Conclusions: In our clinical practice, the SCIP/SIEA and PAP flaps have proven reliable as workhorse flaps for small to large soft tissue defects. For very large defects, the latissimus dorsi flap remains the most reliable solution.